Regulated genomic instability and neoplasia in the lymphoid lineage

Blood

Volumn 94, Issue 12, 1999, Pages 3997-4010

  Vanasse, Gary J ^a   Concannon, Patrick ^a   Willerford, Dennis M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; B LYMPHOCYTE; BLOOM SYNDROME; CHROMOSOME TRANSLOCATION; DNA REPAIR; GENE MUTATION; GENE REARRANGEMENT; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; IMMUNOGLOBULIN GENE; LYMPHOMA; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0032785839     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.3997.424k44_3997_4010     Document Type: Review

References (199)

1. Alt FW, Oltz, EM, Young F, Gorman J, Taccioli G, Chen J: VDJ recombination. Immunol Today 13:313, 1992
2. Willerford DM, Swat W, Alt FW: Developmental regulation of V(D)J recombination and lymphocyte differentiation. Curr Opin Genet Dev 6:603, 1996
3. Oettinger MA, Schatz DG, Gorka C, Baltimore DG: RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517, 1990
4. van Gent DC, McBlane JF, Ramsden DA, Sadofsky MJ, Hesse JE, Gellert M: Initiation of V(D)J recombination in a cell-free system. Cell 81:925, 1995
5. McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Oettinger MA: Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83:387, 1995
6. Eastman QM, Leu TM, Schatz DG: Intitiation of V(D)J recombination in vitro obeying the 12/23 rule. Nature 380:85, 1996
7. van Gent DC, Ramsden DA, Gellert M: The Rag-1 and Rag-2 proteins establish the 12/23 rule in V(D)J recombination. Cell 85:107, 1996
8. Hiom K, Gellert M: Assembly of a 12/23 paired signal complex: A critical control point in V(D)J recombination. Mol Cell 1:1011, 1998
9. Shinkai Y, Rathbun G, Lam KP, M. Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW: RAG-2 deficient mice lack mature lymphocytes owing to inability to initate V(D)J rearrangement. Cell 68:855, 1992
10. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1 deficient mice have no mature B and T lymphocytes. Cell 68:869, 1992
11. Schwartz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR: RAG mutations in human B cell-negative SCID. Science 274:97, 1996
12. Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E: Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93:885, 1998
13. Taccioli GE, Rathbun G, Oltz E, Stamato T, Jeggo PA, Alt FW: Impairment of V(D)J recombination in double-strand break repair mutants. Science 260:207, 1993
14. Taccioli GE, Alt FW: Potential targets for autosomal SCID mutations. Curr Opin Immunol 7:436, 1992
15. Shimizu T, Iwasato T, Yamagishi H: Deletions of immunoglobulin C kappa region characterized by the circular excision products in mouse splenocytes. J Exp Med 173:1065, 1991
16. Roth DB, Lindahl T, Gellert M: Repair and recombination. How to make ends meet. Curr Biol 5:496, 1995
17. Gottlieb TM, Jackson SP: The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell 72:131, 1993
18. Hartley KO, Gell D, Smith GC, Zhang H, Divecha N, Connelly MA, Admon A, Lees-Miller SP, Anderson CW, Jackson SP: DNA-dependent protein kinase catalytic subunit: A relative of phosphatidyl-inositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849, 1995
19. Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottleib TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, Jackson S: Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80:813, 1995
20. Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, Brown JM: DNA-dependent protein kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178, 1995
21. Gao Y, Chaudhuri J, Zhu C, Davidson L, Weaver DT, Alt FW: A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity 9:367, 1998
22. Taccioli GT, Amatucci AG, Beamish HJ, Gell D, Xiang CH, Arzayus MIT, Priestley A, Jackson SP, Rothstein AM, Jeggo PA, Herrera VLM: Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severer combined immunodeficiency and radiosensitivity. Immunity 9:355, 1998
23. Bogue MA, Jhappan C, Roth DB: Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc Natl Acad Sci USA 95:15559, 1998
24. Lieber MR, Hesse JE, Lewis S, Bosma GC, Rosenberg N, Mizuuchi K, Bosma MJ, Gellert M: The defect in murine severe combined immune deficiency: Joining of signal sequences but not coding segments in V(D)J recombination. Cell 55:7, 1988
25. Malynn BA, Blackwell TK, Fulop GM, Rathbun GA, Furley AJW, Ferrier P, Heinke LB, Phillips RA, Yancopoulos GD, Alt FW: The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 54:453, 1988
26. Smider V, Rathmell WK, Lieber MR, Chu G: Restoration of x-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 266:288, 1994
27. Gu Y, Jin S, Gao Y, Weaver DT, Alt FW: Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci USA 94:8076, 1997
28. Zhu C, Bogue MA, Lim D-S, Hasty P, Roth DB: Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86:379, 1996
29. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, Li GC: Requrement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382:551, 1996
30. Ouyang H, Nussenzweig A, Kurimasa A, Soares VC, Li X, Cordon-Cardo C, Li W, Cheong N, Nussenzweig M, Iliakis G, Chen DJ, Li GC: Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J Exp Med 186:921, 1997
31. Gu Y, Seidl K, Rathbun GA, Zhu C, Manis JP, van der Stoep N, Davidson L, Cheng H-L, Skiguchi JM, Frank K, Stanhope-Baker P, Schlissel MS, Roth DB, Alt FW: Growth retardation and leaky scid phenotype of Ku70-deficient mice. Immunity 7:653, 1997
32. Li Z, Otevrel T, Gao Y, Cheng HL, Seed B, Stamato TD, Taccioli GE, Alt FW: The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 83: 1079, 1995
33. Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR: DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell 2:477, 1998
34. Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, Lieber MR: Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388:492, 1997
35. Critchlow SE, Bowater RP, Jackson SP: Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr Biol 7:588, 1997
36. Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL, Davidson L, Kangaloo L, Alt FW: Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 396:173, 1998
37. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JM, Rathbun GA, Swat W, Wang J, Bronson RT, Malynn BA, Bryans M, Zhu C, Chaudhuri J, Davidson L, Ferrini R, Stamato T, Orkin SH, Greenberg ME, Alt FW: A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95:891, 1998
38. Wu Q, Maniatis T: A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97:779, 1999
39. Sleckman BP, Gorman J, Alt FW: Accessibility control of antigen-receptor variable-region gene assembly: Role of cis-acting elements. Annu Rev Immunol 14:459, 1996
40. Stanhope-Baker P, Hudson KM, Shaffer AL, Constantinescu A, Schlissel MS: Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85:887, 1996
41. Villey I, Caillol D, Selz F, Ferrier P, de Villartay J-P: Defect in rearrangement of the most 5′ TCR-Jα following targeted deletion of T early a (TEA): Implications for TCR a locus accessibility. Immunity 5:331, 1996
42. Whitehurst CJ, Chattopadhyay S, Chen J: Control of V(D)J recombinational acessibility of the Dβ1 gene segment at the TCRβ locus by a germline promoter. Immunity 10:313, 1999
43. Stavnezer J: Antibody class switching. Adv Immunol 61:79, 1996
44. Iwasato T, Shimizu A, Honjo T, Yamagishi H: Circular DNA is excised by immunoglobulin class switch recombination. Cell 62:143, 1990
45. Kinoshita K, Tashiro J, Tomita S, Lee CG, Honjo T: Target specificity of immunoglobulin class switch recombination is not determined by nucleotide sequences of S regions. Immunity 9:849, 1998
46. Stavnezer J: Immunoglobulin class switching. Curr Opin Immunol 8:199, 1996
47. Rolink A, Melchers F, Andersson J: The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5:319, 1996
48. Lansford R, Manis JP, Sonoda E, Rajewsky K, Alt FW: Ig heavy chain class switching in Rag-deficient mice. Int Immunol 10:325, 1998
49. Snapper CM, Marcu KB, Zelazowski P: The immunoglobulin class switch: Beyond "accessibility." Immunity 6:217, 1997
50. Cogne M, Lansford R, Bottaro A, Zhang J, Gorman J, Young F, Cheng HL, Alt FW: A class switch control region at the 3′ end of the immunoglobulin heavy chain locus. Cell 77:737, 1994
51. Manis JP, van der Stoep N, Tian M, Ferrini R, Davidson L, Bottaro A, Alt FW: Class switching in B cells lacking 3′ immunoglobulin heavy chain enhancers. J Exp Med 188:1421, 1998
52. Madisen L, Groudine M: Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev 8:2212, 1994
53. Jung S, Rajewsky K, Radbruch A: Shutdown of class switch recombination by deletion of a switch region control element. Science 259:984, 1993
54. Zhang J, Bottaro A, Li S, Stewart V, Alt FW: A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J 12:3529, 1993
55. Bottaro A, Lansford R, Xu L, Zhang J, Rothman P, Alt FW: S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J 13:665, 1994
56. Lorenz M, Jung S, Radbruch A: Switch transcripts in immunoglobulin class switching. Science 267:1825, 1995
57. Hein K, Lorenz MG, Siebenkotten G, Petry K, Christine R, Radbruch A: Processing of switch transcripts is required for targeting of antibody class switch recombination. J Exp Med 188:2369, 1998
58. Manis JP, Gu Y, Lansford R, Sonoda E, Ferrini R, Davidson L, Rajewsky K, Alt FW: Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med 187:2081, 1998
59. Casellas R, Nussenzweig A, Wuerffel R, Pelanda R, Reichlin A, Suh H, Qin XF, Besmer E, Kenter A, Rajewsky K, Nussenzweig MC: Ku80 is required for immunoglobulin isotype switching. EMBO J 17:2404, 1998
60. Neuberger MS, Milstein C: Somatic hypermutation. Curr Opin Immunol 7:248, 1995
61. Storb U: The molecular basis of somatic hypermutation of immunoglobulin genes. Curr Opin Immunol 8:206, 1996
62. Storb U: Progress in understanding the mechanism and consequences of somatic hypermutation. Immunol Rev 162:5, 1998
63. Kim M, Storb U: The role of DNA repair in somatic hypermutation of immunoglobulin genes. J Exp Med 187:1729, 1998
64. Wood RD: DNA repair: Knockouts still mutating after first round. Curr Biol 8:R757, 1998
65. Kelsoe G: V(D)J hypermutation and DNA mismatch repair: Vexed by fixation. Proc Natl Acad Sci USA 95:6576, 1998
66. Vora KA, Tumas-Brundage KM, Lentz VM, Cranston A, Fishel R, Manser T: Severe attenuation of the B cell immune response in Msh2-deficient mice. J Exp Med 189:471, 1999
67. Goossens T, Klein U, Kuppers R: Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci USA 95:2463, 1998
68. Wilson PC, de Bouteiller O, Liu YJ, Potter K, Banchereau J, Capra JD, Pascual V: Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med 187:59, 1998
69. Sale JE, Neuberger MS: TdT-accessible breaks are scattered over the immunoglobulin V domain inn a constitutively hypermutating B cell line. Immunity 9:859, 1998
70. Radic MZ, Zouali M: Receptor editing, immune diversification. and self-tolerance. Immunity 5:505, 1996
71. Nussenzweig MC: Immune receptor editing: Revise and select. Cell 95:875, 1998
72. Chen C, Nagy Z, Prak EL, Weigert M: Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing. Immunity 3:747, 1995
73. Chen C, Prak EL, Weigert M: Editing disease-associated autoantibodies. Immunity 6:97, 1997
74. Jacob J, Kelsoe G, Rajewsky K, Weiss U: Intraclonal generation of antibody mutants in germinal centres. Nature 354:389, 1991
75. Liu YJ, Arpin C: Germinal center development. Immunol Rev 156:111, 1997
76. MacLennan IC, Liu YJ, Johnson GD: Maturation and dispersal of B-cell clones during T cell-dependent antibody responses. Immunol Rev 126:143, 1992
77. Liu YJ, Malisan F, de Bouteiller O, Guret C, Lebecque S, Banchereau J, Mills FC, Max EE, Martinez-Valdez H: Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 4:241, 1996
78. Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G: Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 274:2094, 1996
79. Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmori H: Reexpression of Rag-1 and Rag-2 genes in activated mature mouse B cells. Science 274:2092, 1996
80. Han S, Dillon SR, Zheng B, Shimoda M, Schlissel MS, Kelsoe G: V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 278:301, 1997
81. Papavasiliou F, Casellas R, Suh H, Qin X-F, Besmer E, Pelanda R, Nemazee D, Rajewsky K, Nussenzweig MC: V(D)J recombination in mature B cells: A mechanism for altering antibody responses. Science 278:298, 1997
82. Yu W, Nagaoka H, Jankovic M, Misulorin Z, Suh H, Rulink A, Melchers F, Meltre E, Nussenzweg MC: Continued RAG expression in late stages of B cell development and no apparent reinduction after immunization. Nature 400:682, 1999
83. 82a. Monroe RJ, Seidl KJ, Gaertner F, Han S, Sekiguchi J, Wang J, Ferrini R, Davidson L, Kelsoe G, Alt FW: Rag 2: GFP knockin mice reveal novel aspects of Rag2 expression in primary and peripheral lymphoid tissues. Immunity 11:201, 1999
84. McMahan CJ, Fink PJ: RAG reexpression and DNA recombination at T cell receptor loci in peripheral CD4+ T cells. Immunity 9:637, 1998
85. Drexler HG, MacLeod RAF, Borkhardt A, Janssen JWG: Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 9:480, 1995
86. Finger LR, Harvey RC, Moore RCA, Showe LC, Croce CM: A common michanism of chromosomal translocation in T- and B-cell neoplasia. Science 234:982, 1986
87. Korsmeyer SJ: Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10:785, 1992
88. Magrath I: Molecular basis of lymphomagenesis. Cancer Res 52:5529s, 1992
89. Rabbitts TH: Chromosomal translocations in human cancer. Nature 372:143, 1994
90. Tycko B, Sklar J: Chromosomal translocations in lymphoid neoplasia: A reappraisal of the recombinase model. Cancer Cells 2:1, 1990
91. Showe LC, Croce CM: The role of chromosomal translocations in B- and T-cell neoplasia. Annu Rev Immunol 5:253, 1987
92. Adams JM, Gerondakis S, Webb E, Corcoran LM, Cory S: Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci USA 80:1982, 1983
93. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM: Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824, 1982
94. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P: Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837, 1982
95. Erikson J, Nishikura K, ar-Rushdi A, Finan J, Emanuel B, Lenoir G, Nowell PC, Croce CM: Translocation of an immunoglobulin kappa locus to a region 3′ of an unrearranged c-myc oncogene enhances c-myc transcription. Proc Natl Acad Sci USA 80:7581, 1983
96. Hollis GF, Mitchell KF, Battey J, Potter H, Taub R, Lenoir GM, Leder P: A variant translocation places the lambda immunoglobulin genes 3′ to the c-myc oncogene in Burkitt's lymphoma. Nature 307:752, 1984
97. Lenoir GM, Preud'homme JL, Bernheim A, Berger R: Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 298:474, 1982
98. Henriksson M, Luscher B: Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109, 1996
99. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1, 1999
100. Adams JM, Harris AW, Pinkert CC, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL: The c-myc oncogene driven by immunoglobulin enhancers induced lymphoid malignancies in transgenic mice. Nature 318:533, 1985
101. Langdon WY, Harris AW, Cory S, Adams JM: The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47:11, 1986
102. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P: Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development. Cell 45:485, 1986
103. H on chromosome 14 and near a transcriptional unit on 18. Cell 41:899, 1985
104. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
105. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 22:1390, 1985
106. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
107. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
108. McDonnell TJ, Deane N, Platt FM, Nunez G, Haeger U, McKearn JP, Korsmeyer SJ: bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliteration. Cell 57:79, 1989
109. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254, 1991
110. Strasser A, Harris AW, Cory S: Eμu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin secreting cells but not T cells. Oncogene 8:1, 1993
111. Tycko B, Palmer JD, Sklar J: T cell receptor gene trans-rearrangements: Chimeric γ-δ genes in normal lymphoid tissues. Science 245:1242, 1989
112. Lipkowitz S, Stern M-H, Kirsch IR: Hybrid T cell receptor genes formed by interlocus recombination in normal and Ataxia-telangiectasia lymphocytes. J Exp Med 172:409, 1990
113. Aster JC, Sklar J: Interallelic V(D)J trans-rearrangement within the beta T cell receptor gene is infrequent and occurs preferentially during attempted D beta to J beta joining. J Exp Med 175:1773, 1992
114. Kobayashi Y, Tycko B, Soreng AL, Sklar J: Transrearrangements between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia. J Immunol 147:3201, 1991
115. Tycko B, Reynolds TC, Smith SD, Sklar J: Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia. J Exp Med 169:369, 1989
116. Bakhshi A, Wright JJ, Graninger W, Seto M, Owens J, Cossman J, Jensen JP, Goldman P, Korsmeyer SJ: Mechanism of the t(14;18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84:2396, 1987
117. Neri A, Barriga F, Knowles DM, Magrath IT, Dalla-Favera R: Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 85:2748, 1988
118. Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG: BCL2 oncogene translocation is mediated by a chi-like consensus. J Exp Med 175:1575, 1992
119. Jaeger U, Purtscher B, Delle Karth G, Knap S, Mannhalter C, Lechner K: Mechanism of the chromosomal translocation t(14:18) in lymphoma: Detection of a 45-Kd breakpoint binding protein. Blood 81:1833, 1993
120. Agrawal A, Eastman QM, Schatz DG: Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394:744, 1998
121. Hiom K, Melek M, Gellert M: DNA transposition by the RAG1 and RAG2 proteins: A possible source of oncogenic translocations. Cell 94:463, 1998
122. Gutierrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, de Andreas ML, Epelman S, Risueno C, Magrath IT: Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 79:3261, 1992
123. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I: Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood 77:1516, 1991
124. Cory S, Gerondakis S, Adams JM: Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. EMBO J 2:697, 1983
125. Gerondakis S, Cory S, Adams JM: Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell 36:973, 1984
126. Potter M: Experimental plasmacytomagenesis in mice. Hematol Oncol Clin North Am 11:323, 1997
127. Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM: Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell 3:119, 1999
128. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rejewsky K, Kuppers R: Somatic hypermutation in normal and transformed B cells. Immunol Rev 162:261, 1998
129. Rabbitts TH, Forster A, Hamlyn P, Baer R: Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature 309:592, 1984
130. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R: Frequent somatic hypermutation of the 5′ noncoding region of the BCL6gene in B-cell lymphoma. Proc Natl Acad Sci USA 92:12520, 1995
131. Shen HM, Peters A, Baron B, Zhu X, Storb U: Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750, 1998
132. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K, Dalla-Favera R: BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95:11816, 1998
133. Peng H-Z, Du M-Q, Koulis A, Aiello A, Dogan A, Pan L-X, Isaacson PG: Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood 7:2167, 1999
134. Gatti RA: Ataxia-telangiectasia, in Scrivner CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases for Inherited Disease (ed 8). New York, NY, McGraw-Hill, 1998
135. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749, 1995
136. Morrell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77:89, 1986
137. Taylor AM, Metcalfe JA, Thick J, Mak YF: Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423, 1996
138. Vorechovsky I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster AD, Yuille MA: Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17:96, 1997
139. Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F, Stern MH: Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91:3920, 1998
140. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shim A, James MR, Lichter P, Dohner H: Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3:1155, 1997
141. Yuille MA, Coignet LJ, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle V, Vorechovsky I, Dyer MJ, Catovsky D: ATM is usually rearranged in T-cell prolymphocytic leukaemia. Oncogene 16:789, 1998
142. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA, Taylor AM: Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353:26, 1999
143. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC, Croce CM: ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59:24, 1999
144. Schaffner C, Stilgenbauer S, Rappold GA, Dohner H, Lichter P: Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 94:748, 1999
145. Kojis TL, Gatti RA, Sparkes RS: The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenet 56:143, 1991
146. Ganesh A, North P, Thacker J: Repair and misrepair of site-specific DNA double-strand breaks by human cell extracts. Mutat Res 299:251, 1993
147. Hsieh CL, Arlett CF, Lieber MR: V(D)J recombination in ataxia telangiectasia. Bloom's syndrome, and a DNA ligase I-associated immunodeficiency disorder. J Biol Chem 268:20105, 1993
148. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP, Lavin MF: ATM associates with and phosphorylates p53: Mapping the region of interaction. Nat Genet 20:398, 1998
149. Matsuoka S, Huang M, Elledge SJ: Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282:1893, 1998
150. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677, 1998
151. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674, 1998
152. Weemaes CM, Hustinx TW, Scheres JM, van Munster PJ, Bakkeren JA, Taalman RD: A new chromosomal instability disorder: The Nijmegen breakage syndrome. Acta Paediatr Scand 70:557, 1981
153. Wegner RD, Chrzanowska KH, Spreling K, Stumm M: Ataxia-Telangiectasia variants (Nijmegen breakage syndrome), in Ochs HD, Smith CIE, Puck JM (eds): Primary Immunodeficiency Diseases, a Molecular and Genetic Approach. Oxford, UK, Oxford, 1999
154. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A: Nibrin, a novel DNA double-strand break repair protein is mutated in Nijmegen breakage syndrome. Cell 93:467, 1998
155. Matsuura S, Tauchi H, Nakamura A, Kondo N, Sakamoto S, Endo S, Smeets D, Solder B, Belohradsky BH, Der Kaloustian VM, Oshimura M, Isomura M, Nakamura Y, Komatsu K: Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet 19:179, 1998
156. Carney JP, Mase RS, Olivares H, Davis EM, Le Beau M, Yates JRI, Hays L, Morgan WF, Petrini JHJ: The hMre 11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair Io the cellular DNA damage response. Cell 93:477, 1998
157. Nelms BE, Maser RS, MacKay JF, Lagally MG, Petrini JH: In situ visualization of DNA double-strand break repair in human fibroblasts. Science 280:590, 1998
158. Haber JE: The many interfaces of Mre11. Cell 95:583, 1998
159. Paull TT, Gellen M: The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol Cell 1:969, 1998
160. Paull TT, Gellert M: Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev 13:1276, 1999
161. Critchlow SE, Jackson SP: DNA end-joining: from yeast to man. Trends Biochem Sci 23:394, 1998
162. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, Ciocci S, Proytcheva M, German J: The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83:655, 1995
163. German J: Bloom's syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet 93:100, 1997
164. Chaganti RS, Schonberg S, German J: A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. Proc Natl Acad Sci USA 71:4508, 1974
165. Warren ST, Schultz RA, Chang CC, Wade MH, Trosko JE: Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc Natl Acad Sci USA 78:3133, 1981
166. Langlois RG, Bigbee WL, Jensen RH, German J: Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Proc Natl Acad Sci USA 86:670, 1989
167. Sack SZ, Liu Y, German J, Green NS: Somatic hypermutation of immunoglobulin genes is independent of the Bloom's syndrome DNA helicase. Clin Exp Immunol 112:248, 1998
168. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215, 1992
169. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA Jr, Park SH, Thompson T, Ford RJ, Bradley A: Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinogen 14:16, 1995
170. Bosma MJ, Carroll AM: The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 9:323, 1991
171. Bogue MA, Zhu C, Aguilar-Cordova E, Donehower LA, Roth DB: p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev 10:553, 1996
172. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF, Danska JS: V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev 10:2038, 1996
173. Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT, Jacks T: Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev 10:2055, 1996
174. Vanasse GJ, Halbrook J, Thomas S, Burgess A, Hoekstra M, Disteche CM, Willerford DM: Genetic pathway to recurrent chromosome translocations in marine lymphoma involves V(D)J recombinase. J Clin Invest 103:1669, 1999
175. Liao MJ, Zhang XX, Hill R, Gao J, Qumsiyeh MB, Nichols W, Van Dyke T: No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol 18:3495, 1998
176. Nacht M, Jacks T: V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Differ 9:131, 1998
177. Kastan MB, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh W, Plunkett B, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectaia. Cell 71:587, 1992
178. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
179. Lowe S, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847, 1993
180. Danska JS, Guidos CJ: Essential and perilous: V(D)J recombination and DNA damage checkpoints in lymphocyte precursors. Semin Immunol 9:199, 1997
181. Diamond RA, Ward SB, Owada-Makabe K, Wang H, Rothenberg EV: Different developmental arrest points in Rag-2-/- and SCID thymocytes on two genetic backgrounds. J Immunol 158:4052, 1997
182. Gutierrez MI, Bhatia K, Cherney B, Capello D, Gaidano G, Magrath I: Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma. Ann Oncol 8:987, 1997
183. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49, 1991
184. Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K, Saito H, Hotta T: Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 337:529, 1997
185. Li F, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW: A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358, 1988
186. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233, 1990
187. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323, 1997
188. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A: Atm-dencient mice: A paradigm of ataxia telangiectasia. Cell 86:159, 1996
189. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schrock E, Ried T: Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 14:312, 1996
190. Li GC, Ouyang H, Li X, Nagasawa H, Little JB, Chen DJ, Ling CC, Fuks Z, Cordon-Cardo C: Ku70: A candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell 2:1, 1998
191. Morrison C, Smith GCM, Stingl L, Jackson SP, Wagner EF, Wang Z-Q: Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat Genet 17:479, 1997
192. Baross-Francis A, Andrew SE, Penney JE, Jirik FR: Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc Natl Acad Sci USA 95:8739, 1998
193. de Wind N, Dekker M, Berns A, Radman M, te Riele H: Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82:321, 1995
194. Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrucker HW, Wakeham A, Liu B, Thomason A, Griesser H, Gallinger S, Ballhausen WG, Fishel R, Mak TW: MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11:64, 1995
195. Shi YP, Mohapatra G, Miller J, Hanahan D, Lander E, Gold P, Pinkel D, Gray J: FISH probes for mouse chromosome identification. Genomics 45:42, 1997
196. Han JO, Steen SB, Roth DB: Intermolecular V(D)J recombination is prohibited specifically at the joining step. Mol Cell 3:331, 1999
197. Lin WC, Desiderio S: Cell cycle regulation of V(D)J recombination-activating protein RAG-2. Proc Natl Acad Sci USA 91:2733, 1994
198. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
199. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417, 1997 (special number)